Earlier this week, Walgreens (WBA) warned investors that profits would take a dive from previous estimates as a result of weakened consumer spending and dwindling demand for COVID-19 vaccinations. As a result, shares dropped more than 9% this week - now reaching their lowest levels in over a decade. CEO Rosalind Brewer noted that [...]
At one point, Canopy Growth (CGC) was valued at $19 billion. The stock traded at over $50/share at its peak. But today? It sits at a mere $0.49/share. And as dramatic a fall from grace as this story already is, one analyst expects the true end is near. Benchmark analyst Mike Hickey believes Canopy [...]
While much of the recent focus within the stock market has been placed on the AI trend, one stock in the pharmaceutical industry has been on a surge so far this year: Eli Lilly (LLY). The stock sat at just $311/share at the start of March. And today, the stock sits at $452/share. But, [...]
Columbia Care Inc. (CCHWF) started the week with a bang, releasing its 1st quarter earnings report and exceeding analyst expectations. As a result, the stock has climbed more than 20%. But as you’ll discover below, there are still 3 major issues investors should be aware of. The cannabis company posted revenue of $124.54 million, [...]
Protalix BioTherapeutics, Inc. (PLX: NYSE AMEX and Tel Aviv Stock Exchange) is headquartered in Carmiel, Israel with an office in Hackensack, NJ, with a total of 197 employees. Protalix Ltd. was incorporated in 1993. It became a U.S public company on December 31, 2006. PLX is a biopharmaceutical company that develops, produces and commercializes [...]
Yesterday, Amneal Pharmaceuticals (AMRX) issued guidance for the first quarter of 2023 that came in over the consensus estimates. This sent shares trading as much as 14% higher in premarket trading. The stock opened Monday’s trading session at $1.34/share and closed at $1.63 for a nice single-day gain. The pharmaceutical company says that revenue [...]
This morning, UnitedHealth Group (UNH) reported first-quarter earnings that came in over expectations. The company doubled down on this success, raising the full-year outlook for 2023. And yet, shares of the company are falling - down nearly 3% in Friday’s trading session so far. This has investors and the market as a whole perplexed. [...]
Pfizer (PFE) has climbed more than 2% in this shortened trading week, and this could be due to the recent advancements in their latest vaccine. The RSV (respiratory syncytial virus) vaccine has been found to be 82% effective in preventing a respiratory virus in infants. The way the vaccine works is through administration to [...]
Elevance Health, Inc., (ELV:NYSE), founded in 1944 is based in Indianapolis. It is a health benefits provider that supports health at each life stage, providing health plans and clinical, behavioral, pharmacy, and complex-care solutions that promote members' whole health. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, [...]
Last week Moderna (MRNA) announced a licensing deal with Generation Bio that they hope will allow them to overcome the losses they’re facing now that the COVID-19 pandemic has come and gone. And as a result of this deal, Generation Bio (GBIO) gained 34% in the past week of trading. The partnership will have [...]
